Clinical Trial Update: Evaluation of a Nigella Sativa Extract (10% Thymoquinone, Nisatol®) in Perimenopausal Women With Metabolic Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating Nisatol, a Nigella sativa extract standardized to 10% thymoquinone, in perimenopausal women with metabolic syndrome. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Nisatol (Nigella sativa)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Metabolic Syndrome, Elevated Blood Pressure | NA | Status: COMPLETED